CYP46A1 and Alzheimer disease: Increased 24S-HC levels in both plasma and cerebrospinal fluid have been observed at early stages of AD, and as the disease progresses, 24S-HC levels decrease, possibly reflecting extensive neuronal loss and resultant loss of the CYP46A1 enzyme.